The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis.
about
Parallel Aspects of the Microenvironment in Cancer and Autoimmune DiseaseThe impact of the myeloid response to radiation therapyClinical significance of tumor-infiltrating lymphocytes in breast cancerThe roles of TGFβ in the tumour microenvironment.TNF superfamily protein-protein interactions: feasibility of small- molecule modulationWhy has active immunotherapy not worked in lung cancer?A comparison of epithelial-to-mesenchymal transition and re-epithelializationThe TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy.Targeting tumor-necrosis factor receptor pathways for tumor immunotherapyTherapeutic vaccines for cancer: an overview of clinical trials.The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis.TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner.Targeting TGF-β Signaling for Therapeutic Gain.Tumor immune remodeling by TGFβ inhibition improves the efficacy of radiation therapy.Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors.Tumor-targeted costimulation with antibody-fusion proteins improves bispecific antibody-mediated immune response in presence of immunosuppressive factors.Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.TGF-β in T Cell Biology: Implications for Cancer Immunotherapy.
P2860
Q26753174-ED7B34CA-5ABC-4126-8549-9D0877D975EFQ26851643-36C8FA6F-2409-43C6-BF3D-5145BF1EB531Q28070214-E03BFFC5-CF69-4A73-A237-2CDFBE93C031Q33630845-5AF59A31-233B-48EC-B374-041979079D52Q35534271-A7FCCBF3-7E7A-4675-9A9D-AAC07FD8FD78Q36207901-6F0497C0-64D6-4490-B4F2-1C513784FD23Q36678367-BFD36D35-BC0B-4880-A161-E8C78048D6D4Q38081999-4BAE1158-BECA-4D4C-A4DD-42E0090831E1Q38214095-B0382017-B4F4-4169-B4CD-2863B8B56A86Q38227030-FCBC171E-82A6-4834-85DE-E9108AE452A6Q38291631-9CA008E7-F696-45A9-B63E-020E3B91ECEBQ38632049-A2F6AE2C-A2BD-42CC-995B-6947B8909763Q39155151-59A94B8D-7DEF-4DB2-9BA8-E9584621D0B4Q39833083-7B74CF72-EA70-498D-AE15-2149DF3A89EAQ42380337-20071A98-E09C-4198-A77F-00C7859DE766Q47325439-FFE4BD2E-3E34-4198-9EAC-D1AE361F2836Q49435928-F18D0D74-F0C6-41BD-852A-BA7A68E747E3Q55515390-6218DF8F-49E6-437B-909E-41EE3DEFD659
P2860
The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The small molecule TGF-β signa ...... reduce spontaneous metastasis.
@ast
The small molecule TGF-β signa ...... reduce spontaneous metastasis.
@en
type
label
The small molecule TGF-β signa ...... reduce spontaneous metastasis.
@ast
The small molecule TGF-β signa ...... reduce spontaneous metastasis.
@en
prefLabel
The small molecule TGF-β signa ...... reduce spontaneous metastasis.
@ast
The small molecule TGF-β signa ...... reduce spontaneous metastasis.
@en
P2093
P2860
P1476
The small molecule TGF-β signa ...... reduce spontaneous metastasis.
@en
P2093
Andrew D Weinberg
Emmanuel T Akporiaye
Kendra Garrison
Leona E Ling
Tobias Hahn
Wen-Cherng Lee
P2860
P2888
P304
P356
10.1007/S00262-011-1119-Y
P577
2011-10-05T00:00:00Z